Bayer (Schweiz) AG - Vitrakvi 25 mg, Kapseln Swissmedic Registration 67281 Sequence 01 Product name Vitrakvi 25 mg Description Kapseln ATC-Classification L01EX12 ATC-Description Introduction of Sequence 28.05.2020
Composition larotrectinibum 25 mg ut larotrectinibi sulfas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 132, E 171, propylenglycolum, dimeticonum 1000, pro capsula. Packungsbestandteile Galenic Form Capsules BAG: Active Agent Dose 25 mg
Inactive agents Dose additional_information Dimeticone 1000 color. color. Gelatina Kapselhülle Drucktinte Propylenglycol
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 56 1351.24 1485.95 A SL No
